Literature DB >> 8625469

Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.

D Wang1, C M Weghorst, R J Calvert, G D Stoner.   

Abstract

Mutations in the p53 tumor suppressor gene have been implicated in the pathogenesis of a wide variety of human neoplasms. The location and types of p53 gene mutation can reflect exposure of humans to certain types carcinogenic agents. Much less is known about the role of p53 mutational inactivation in rodent tumors. Using both 'Hot' (radioactive) and 'Cold' (non-radioactive) single strand conformation polymorphism (SSCP) analyses, the present study of analyzed exons 5-8 and the exon-intron junction of the p53 gene from rat esophageal papillomas induces by N- nitrosomethylbenzylamine (NMBA) for mutations. Nine of 30 (30%) esophageal papillomas contained SSCP mobility shifts, principally within exons 5 and 7. These positive SSCP findings were further validated by direct DNA sequencing analysis. Eight of the nine mutations were G:C-->A:T transitions in codons 131, 149, 153, 242 (2), 243, 248, and the 5 end of intron 7. None of these G:C-->A:T mutations occurred at the CpG sites. The other mutation was a frameshift mutation in codon 176. The G:C-A:T transitions observed in this study are consistent with the documented formation of O(6)-methylguanine adducts in DNA N-nitroso compounds. These results suggest that point mutations of the p53 gene are involved in the development of approximately one-third of NMBA-induced rat esophageal papillomas. 'Hot' and 'Cold' SSCP methods were equally sensitive for the identification of mutations in the rat p53 gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625469     DOI: 10.1093/carcin/17.4.625

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Chemopreventive effects of early-stage and late-stage supplementation of vitamin E and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet.

Authors:  Hui Yang; Jin Fang; Xudong Jia; Chi Han; Xiaoxin Chen; Chung S Yang; Ning Li
Journal:  Carcinogenesis       Date:  2010-12-24       Impact factor: 4.944

2.  FBXO4 loss facilitates carcinogen induced papilloma development in mice.

Authors:  Zhaorui Lian; Eric K Lee; Adam J Bass; Kwok K Wong; Andres Jp Klein-Szanto; Anil K Rustgi; J Alan Diehl
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 3.  Personalized targeted therapy for esophageal squamous cell carcinoma.

Authors:  Xiaozheng Kang; Keneng Chen; Yicheng Li; Jianying Li; Thomas A D'Amico; Xiaoxin Chen
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 4.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

5.  Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice.

Authors:  David J Feith; Anthony E Pegg; Louise Y Y Fong
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

6.  4-Methylthio-3-butenyl isothiocyanate (raphasatin) exerts chemopreventive effects against esophageal carcinogenesis in rats.

Authors:  Isamu Suzuki; Young-Man Cho; Tadashi Hirata; Takeshi Toyoda; Jun-Ichi Akagi; Yasushi Nakamura; Eun Young Park; Azusa Sasaki; Takako Nakamura; Shigehisa Okamoto; Koji Shirota; Noboru Suetome; Akiyoshi Nishikawa; Kumiko Ogawa
Journal:  J Toxicol Pathol       Date:  2016-07-04       Impact factor: 1.628

7.  Tumorigenic conversion of a rat urothelial cell line by human polymorphonuclear leukocytes activated by lipopolysaccharide.

Authors:  T Tamatani; P Turk; S Weitzman; R Oyasu
Journal:  Jpn J Cancer Res       Date:  1999-08

8.  p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.

Authors:  K Shimokado; H Watanabe; M Sumii; K Miyagawa; K Kamiya; K Dohi; O Niwa
Journal:  Jpn J Cancer Res       Date:  1998-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.